Exciting Advances in Sustainable Spectrophotometric Micro-Quantitation of an Innovative Painkiller “Tramadol and Celecoxib” Mixture in the Presence of a Toxic Impurity, Promoting Greenness and Whiteness Studies
- 9 December 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 107 (2) , 362-370
Abstract
Tramadol (TRM) and celecoxib (CLX) are a novel mixture that helps relieve impetuous, acute pain when other painkillers have no action. It is also reported that the currently studied drugs, tramadol and celecoxib, are used to control COVID-19 symptoms. The current work highlights three important pillars of modern pharmaceutical analysis, which are as follows; impurity profiling, greenness/whiteness studies and simplicity accompanied by sensitivity. Since 4-methyl acetophenone inhibits the human carbonyl reductase enzyme (type I), and since this compound may pose a health risk, it is crucial to regulate its concentration in all dosage forms of CLX. Two simple and green spectrophotometric methods were developed, namely; Third Derivative (D3) and Fourier Self Deconvulation (FSD) for resolving severely overlapped spectra of tramadol and celecoxib in the presence of 4-methyl acetophenone (4-MAP) as a process-related impurity in their novel tablet combination. The two approaches showed acceptable linearity with an excellent correlation coefficient. Simply, for both methods tramadol was measured when celecoxib and 4-methyl acetophenone were zero-crossing. The same procedure was applied for measuring celecoxib and its process-related impurity; 4-methyl acetophenone. The methodologies developed were thoroughly validated in compliance with ICH guidelines. Student t and F-tests revealed no statistically substantial variation among the current methods and the reported method. No spectrophotometric methods have been published for the simultaneous analysis of TRM and CLX along with 4-MAP. As a result, the newly developed spectrophotometric approaches hold great relevance and originality in the field of pharmaceutical analysis.Keywords
This publication has 39 references indexed in Scilit:
- Co-crystal of Tramadol Hydrochloride–Celecoxib (ctc): A Novel API–API Co-crystal for the Treatment of PainCrystal Growth & Design, 2017
- Simultaneous Determination of Tramadol and O-Desmethyltramadol in Human Plasma Using HPLC–DADJournal of Chromatographic Science, 2013
- Stability evaluation of tramadol enantiomers using a chiral stability‐indicating capillary electrophoresis method and its application to pharmaceutical analysisJournal of Separation Science, 2011
- Combination Drug Therapy for Chronic Pain: A Call for More Clinical StudiesThe Journal of Pain, 2011
- Simultaneous voltammetric determination of tramadol and acetaminophen using carbon nanoparticles modified glassy carbon electrodeElectrochimica Acta, 2010
- Validated LC Method for Simultaneous Analysis of Tramadol Hydrochloride and Aceclofenac in a Commercial TabletChromatographia, 2008
- Carbonyl Reductases: The Complex Relationships of Mammalian Carbonyl- and Quinone-Reducing Enzymes and Their Role in PhysiologyAnnual Review of Pharmacology and Toxicology, 2007
- Inhibition of carbonyl reductase activity in pig heart by alkyl phenyl ketonesJournal of Enzyme Inhibition and Medicinal Chemistry, 2007
- Spectrophotometric and spectrofluorimetric methods for analysis of tramadol, acebutolol and dothiepin in pharmaceutical preparationsSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2006
- Simultaneous determination of celecoxib, meloxicam, and rofecoxib using capillary electrophoresis with surfactant and application in drug formulationsJournal of Separation Science, 2006